Pomerantz LLP is investigating LENZ Therapeutics and some of its executives for potential securities fraud following the company's weak Q2 2026 results. LENZ reported $5.5 million in revenue, mostly from one-time licensing deals, with flat sales of its main eye drop product, VIZZ, which grew only 9% in volume. This led Bank of America to downgrade LENZ stock and slash its price target, causing a sharp stock price decline that hurt investors. The investigation aims to determine if LENZ and its officers misled investors about the company's performance.
The story concerns LENZ Therapeutics amid its securities fraud investigation. For readers following the health sector, here is Pluang's market snapshot as of Sep 25, 2026 04:41 WIB: Of 100 priced US health stocks, 38 rose and 62 fell. Notable movers include ASND at USD 221.34 with a 1-day change of -6.83% and 100% sell order activity, RVTY at USD 150.90 with a 6.19% gain and balanced buy/sell orders, and BNGO at USD 1.71 down 6.04% but with 87% buy orders. Typical hold times range from 11 to 55 days among these stocks.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
